APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haloperidol

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Haloperidol Market Outlook and Growth Opportunities 2026

Report ID 173996900427 December 2025195 pages

Choose your research edition.

Industry ResearchHaloperidol Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Haloperidol Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Haloperidol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haloperidol Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Haloperidol Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Haloperidol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Haloperidol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Haloperidol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haloperidol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Haloperidol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Haloperidol market include Teva, Sandoz, Mylan, Zydus, Gland Pharma and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Haloperidol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Haloperidol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Haloperidol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Haloperidol market size, projected growth trends, production technologies, key applications, and end-use industries.

Haloperidol Segment by Company

Teva

Sandoz

Mylan

Zydus

Gland Pharma

Fresenius Kabi

Haloperidol Segment by Type

Oral

Injection

Haloperidol Segment by Application

Mental Disease

Others

Haloperidol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Haloperidol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Haloperidol market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Haloperidol significant trends, drivers, influence factors in global and regions.

6. To analyze Haloperidol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haloperidol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haloperidol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haloperidol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Haloperidol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Haloperidol industry.

Chapter 3: Detailed analysis of Haloperidol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Haloperidol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Haloperidol in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Haloperidol Industry Trends Table 2. Haloperidol Industry Drivers Table 3. Haloperidol Industry Opportunities and Challenges Table 4. Haloperidol Industry Restraints Table 5. Global Haloperidol Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Haloperidol Revenue Share by Company (2021-2026) Table 7. Global Haloperidol Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Haloperidol Sales Volume Share by Company (2021-2026) Table 9. Global Haloperidol Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Haloperidol Company Ranking, (2024-2026) & (USD Million) Table 11. Global Haloperidol Key Company Manufacturing Base & Headquarters Table 12. Global Haloperidol Company, Product Type & Application Table 13. Global Haloperidol Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Haloperidol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Injection Table 19. Global Haloperidol Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Haloperidol Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Haloperidol Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Haloperidol Sales Volume Share by Type (2021-2026) Table 23. Global Haloperidol Sales Volume Share by Type (2027-2032) Table 24. Global Haloperidol Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Haloperidol Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Haloperidol Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Haloperidol Sales Value Share by Type (2021-2026) Table 28. Global Haloperidol Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Mental Disease Table 30. Significant Companies of Others Table 31. Global Haloperidol Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Haloperidol Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Haloperidol Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Haloperidol Sales Volume Share by Application (2021-2026) Table 35. Global Haloperidol Sales Volume Share by Application (2027-2032) Table 36. Global Haloperidol Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Haloperidol Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Haloperidol Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Haloperidol Sales Value Share by Application (2021-2026) Table 40. Global Haloperidol Sales Value Share by Application (2027-2032) Table 41. Global Haloperidol Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Haloperidol Sales by Region (2021-2026) & (Tons) Table 43. Global Haloperidol Sales Market Share by Region (2021-2026) Table 44. Global Haloperidol Sales by Region (2027-2032) & (Tons) Table 45. Global Haloperidol Sales Market Share by Region (2027-2032) Table 46. Global Haloperidol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Haloperidol Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Haloperidol Sales Value Share by Region (2021-2026) Table 49. Global Haloperidol Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Haloperidol Sales Value Share by Region (2027-2032) Table 51. Global Haloperidol Market Average Price (US$/Ton) by Region (2021-2026) Table 52. Global Haloperidol Market Average Price (US$/Ton) by Region (2027-2032) Table 53. Global Haloperidol Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Haloperidol Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Haloperidol Sales by Country (2021-2026) & (Tons) Table 56. Global Haloperidol Sales Market Share by Country (2021-2026) Table 57. Global Haloperidol Sales by Country (2027-2032) & (Tons) Table 58. Global Haloperidol Sales Market Share by Country (2027-2032) Table 59. Global Haloperidol Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Haloperidol Sales Value Market Share by Country (2021-2026) Table 61. Global Haloperidol Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Haloperidol Sales Value Market Share by Country (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Teva Haloperidol Product Portfolio Table 67. Teva Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Sandoz Haloperidol Product Portfolio Table 72. Sandoz Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Mylan Haloperidol Product Portfolio Table 77. Mylan Recent Development Table 78. Zydus Company Information Table 79. Zydus Business Overview Table 80. Zydus Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Zydus Haloperidol Product Portfolio Table 82. Zydus Recent Development Table 83. Gland Pharma Company Information Table 84. Gland Pharma Business Overview Table 85. Gland Pharma Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Gland Pharma Haloperidol Product Portfolio Table 87. Gland Pharma Recent Development Table 88. Fresenius Kabi Company Information Table 89. Fresenius Kabi Business Overview Table 90. Fresenius Kabi Haloperidol Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Fresenius Kabi Haloperidol Product Portfolio Table 92. Fresenius Kabi Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Haloperidol Distributors List Table 96. Haloperidol Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Haloperidol Product Image Figure 2. Global Haloperidol Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haloperidol Sales Value (2021-2032) & (US$ Million) Figure 4. Global Haloperidol Sales (2021-2032) & (Tons) Figure 5. Global Haloperidol Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Haloperidol Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Injection Image Figure 11. Global Haloperidol Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Haloperidol Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Haloperidol Sales Volume Share by Type (2021-2032) Figure 14. Global Haloperidol Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Haloperidol Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Haloperidol Sales Value Share by Type (2021-2032) Figure 17. Mental Disease Image Figure 18. Others Image Figure 19. Global Haloperidol Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Haloperidol Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Haloperidol Sales Volume Share by Application (2021-2032) Figure 22. Global Haloperidol Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Haloperidol Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Haloperidol Sales Value Share by Application (2021-2032) Figure 25. Global Haloperidol Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Haloperidol Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Haloperidol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Haloperidol Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Haloperidol Sales Value (2021-2032) & (US$ Million) Figure 30. North America Haloperidol Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Haloperidol Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Haloperidol Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Haloperidol Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Haloperidol Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Haloperidol Sales Value (2021-2032) & (US$ Million) Figure 36. South America Haloperidol Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Haloperidol Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Haloperidol Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Haloperidol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Haloperidol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Haloperidol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Haloperidol Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Haloperidol Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Mental Disease
  • Others
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Zydus
  • Gland Pharma
  • Fresenius Kabi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Haloperidol Sales Value (2021-2032)
  4. 1.2.2 Global Haloperidol Sales Volume (2021-2032)
  5. 1.2.3 Global Haloperidol Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Haloperidol Market Dynamics
  1. 2.1 Haloperidol Industry Trends
  2. 2.2 Haloperidol Industry Drivers
  3. 2.3 Haloperidol Industry Opportunities and Challenges
  4. 2.4 Haloperidol Industry Restraints
3 Haloperidol Market by Company
  1. 3.1 Global Haloperidol Company Revenue Ranking in 2025
  2. 3.2 Global Haloperidol Revenue by Company (2021-2026)
  3. 3.3 Global Haloperidol Sales Volume by Company (2021-2026)
  4. 3.4 Global Haloperidol Average Price by Company (2021-2026)
  5. 3.5 Global Haloperidol Company Ranking (2024-2026)
  6. 3.6 Global Haloperidol Company Manufacturing Base and Headquarters
  7. 3.7 Global Haloperidol Company Product Type and Application
  8. 3.8 Global Haloperidol Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Haloperidol Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Haloperidol Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Haloperidol Market by Type
  1. 4.1 Haloperidol Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Haloperidol Sales Volume by Type
  5. 4.2.1 Global Haloperidol Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Haloperidol Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Haloperidol Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Haloperidol Sales Value by Type
  9. 4.3.1 Global Haloperidol Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Haloperidol Sales Value by Type (2021-2032)
  11. 4.3.3 Global Haloperidol Sales Value Share by Type (2021-2032)
5 Haloperidol Market by Application
  1. 5.1 Haloperidol Application Introduction
  2. 5.1.1 Mental Disease
  3. 5.1.2 Others
  4. 5.2 Global Haloperidol Sales Volume by Application
  5. 5.2.1 Global Haloperidol Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Haloperidol Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Haloperidol Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Haloperidol Sales Value by Application
  9. 5.3.1 Global Haloperidol Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Haloperidol Sales Value by Application (2021-2032)
  11. 5.3.3 Global Haloperidol Sales Value Share by Application (2021-2032)
6 Haloperidol Regional Sales and Value Analysis
  1. 6.1 Global Haloperidol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Haloperidol Sales by Region (2021-2032)
  3. 6.2.1 Global Haloperidol Sales by Region: 2021-2026
  4. 6.2.2 Global Haloperidol Sales by Region (2027-2032)
  5. 6.3 Global Haloperidol Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Haloperidol Sales Value by Region (2021-2032)
  7. 6.4.1 Global Haloperidol Sales Value by Region: 2021-2026
  8. 6.4.2 Global Haloperidol Sales Value by Region (2027-2032)
  9. 6.5 Global Haloperidol Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Haloperidol Sales Value (2021-2032)
  12. 6.6.2 North America Haloperidol Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Haloperidol Sales Value (2021-2032)
  15. 6.7.2 Europe Haloperidol Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Haloperidol Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Haloperidol Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Haloperidol Sales Value (2021-2032)
  21. 6.9.2 South America Haloperidol Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Haloperidol Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Haloperidol Sales Value Share by Country, 2025 VS 2032
7 Haloperidol Country-level Sales and Value Analysis
  1. 7.1 Global Haloperidol Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Haloperidol Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Haloperidol Sales by Country (2021-2032)
  4. 7.3.1 Global Haloperidol Sales by Country (2021-2026)
  5. 7.3.2 Global Haloperidol Sales by Country (2027-2032)
  6. 7.4 Global Haloperidol Sales Value by Country (2021-2032)
  7. 7.4.1 Global Haloperidol Sales Value by Country (2021-2026)
  8. 7.4.2 Global Haloperidol Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Haloperidol Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Haloperidol Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Haloperidol Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Haloperidol Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Haloperidol Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Haloperidol Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Haloperidol Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Haloperidol Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Haloperidol Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Haloperidol Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Haloperidol Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Haloperidol Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Haloperidol Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Haloperidol Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Haloperidol Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Haloperidol Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Haloperidol Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Haloperidol Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Haloperidol Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Haloperidol Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Haloperidol Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Haloperidol Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Haloperidol Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Haloperidol Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Haloperidol Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Haloperidol Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Haloperidol Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Haloperidol Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Haloperidol Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Haloperidol Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Haloperidol Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Haloperidol Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Haloperidol Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Haloperidol Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Haloperidol Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Haloperidol Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Haloperidol Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Haloperidol Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Haloperidol Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Haloperidol Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Haloperidol Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Haloperidol Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Haloperidol Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Haloperidol Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Haloperidol Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Haloperidol Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Haloperidol Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Haloperidol Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Haloperidol Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Haloperidol Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Haloperidol Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Haloperidol Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Haloperidol Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Haloperidol Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Haloperidol Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Haloperidol Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Haloperidol Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Haloperidol Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Haloperidol Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Haloperidol Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Haloperidol Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Haloperidol Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Haloperidol Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Haloperidol Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Haloperidol Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Haloperidol Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Haloperidol Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Haloperidol Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Haloperidol Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Haloperidol Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Haloperidol Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Haloperidol Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Haloperidol Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Haloperidol Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Haloperidol Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Haloperidol Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Haloperidol Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Haloperidol Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Haloperidol Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Haloperidol Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Haloperidol Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Haloperidol Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Haloperidol Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Haloperidol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Haloperidol Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Haloperidol Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Haloperidol Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Haloperidol Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Haloperidol Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Haloperidol Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Zydus
  20. 8.4.1 Zydus Company Information
  21. 8.4.2 Zydus Business Overview
  22. 8.4.3 Zydus Haloperidol Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zydus Haloperidol Product Portfolio
  24. 8.4.5 Zydus Recent Developments
  25. 8.5 Gland Pharma
  26. 8.5.1 Gland Pharma Company Information
  27. 8.5.2 Gland Pharma Business Overview
  28. 8.5.3 Gland Pharma Haloperidol Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gland Pharma Haloperidol Product Portfolio
  30. 8.5.5 Gland Pharma Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi Haloperidol Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Haloperidol Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Haloperidol Value Chain Analysis
  2. 9.1.1 Haloperidol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Haloperidol Sales Mode & Process
  6. 9.2 Haloperidol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Haloperidol Distributors
  9. 9.2.3 Haloperidol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst